The EACR & NanoString in collaboration with Illumina co-sponsor a research award for Spatial Biology
The European Association for Cancer Research (EACR) & NanoString, in collaboration with Illumina, will award the most impactful proposal in cancer immunotherapy research with the ability to discover spatial biomarkers using the latest Digital Spatial Profiling chemistry. The NanoString GeoMx® Cancer Transcriptome Atlas (CTA) for use with the GeoMx® Digital Spatial Profiler (DSP) blends high-plex and spatial analysis in a single experiment. With CTA you can profile over 1,800 genes for every region of interest on your tissue. The read out will be performed with the Illumina NextSeq™ 2000 Sequencing System located at NanoString’s premises.
The grant is exclusive to EACR members - Learn more about EACR membership.
Spatially Resolve the Cancer Transcriptome:
- Evaluate 13 canonical cancer pathways, and 55 common functional ontologies related to micro-environment and tumor biology.
- Unique profiling feature allows quantification of the relative abundance of immune cell populations, tumor signatures and micro-environment genes.
- Data analysis service is provided by expert NanoString scientists to help you quickly gain the most insight from your data.
- Utilizing the Illumina NextSeq™ 2000 Sequencing System and associated reagent kit for the NGS readout will allow you to unveil critical markers of cancer biology and drive your project to the next level.
Win a free CTA project with NGS readout on Illumina's new NextSeq™ 2000 Sequencing System
- The grant winner will provide 4 samples to NanoString, with up to 12 regions of interest per sample to be mutually agreed upon, to be used with the GeoMx CTA.
- The winner provide samples, NanoString provides the DSP reagent, Illumina will provide the reagents for the NGS readout. NanoString will perform the DSP TAP (Technology Access Program) Services.
- NanoString will provide a data analysis service to analyze the data output from the experiment in the form of a report that includes raw data and detailed analysis with figures and commentary.
- Submission must be received by July 31, 2020.
*See terms and conditions below
Grant applications have now closed.
Terms and Conditions
Publication of Project Results:
All grant submissions are confidential to the individual submitter and will not be published or distributed, provided, however, that NanoString may share them with their own staff and distributors who will not disclose to third party. Illumina will support the grant advertising efforts and will provide the reagent kit for the NGS readout. Illumina will not receive any information on the projects submitted or the submissions themselves. Nanostring will be provide Illumina with the names and email addresses of all applicants as well as their affiliated institution.
The winner will be selected by a panel of judges that includes EACR Board members, as well as representation from NanoString. The winner's announcement and results will be made at a large EACR webinar which will be also be hosted on the EACR YouTube channel, upon agreement with the winner.
Upon project completion, the grant winner agrees to participate in at least one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by NanoString, Illumina and the EACR and the winner: webinar, case study, blog post, or poster presentation. The winner agrees that NanoString and the EACR shall have the right to publicly announce the winner’s name and research title and use anonymized data from the winner's projects in application notes including in marketing materials and seminars- no public display of data will happen without previous consent from the winner.
Eligibility and Requirements:
• Applicants must be actively enrolled or employed at a research institution in a capacity in which they perform life science research and have the ability to ship and analyze samples within 45 days of award notification.
• Applicants must be EACR members.
• Applicants must not be government employees or a Health Care Professionals. Employees of government institutions and Health Care Professionals should not be eligible to participate in the program. Health Care Professional is defined as physicians, nurses, physician assistants, pharmacists, and any other medical professionals, including without limitation, medical students, laboratory directors, genetic counselors, and formulary committee members.
• Members of the immediate families of the EACR, Illumina and NanoString employees and directors, and/or persons living in the same household as such persons, are ineligible to participate in this grant program.
• This program is void where prohibited or otherwise restricted by law. The grant winner will provide 4 samples to NanoString, with up to 12 Regions of Interest (ROI) per sample to be mutually agreed upon, to be used with the GeoMx® Cancer Transcriptome Atlas RNA and Illumina NGS appropriate reagents for use with the Illumina NextSeq™ 2000 Sequencing System.
• The samples will run through NanoString’s GeoMx® Digital Spatial Profiling Technology Access Program inclusive of the Illumina NGS readout. An assay report, including raw data and processed results, will be provided to the winner.
By submitting a grant application, each applicant agrees that NanoString may use his or her name, abstract title, for marketing purposes.
All grant applicants agree that NanoString may process the personal data he or she provides as part of application, including sharing such data with NanoString’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with NanoString’s privacy policies available at www.nanostring.com/privacy.
Please find the EACR privacy notice here.
The grant award winner may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by NanoString. No substitution or transfer of the awarded prize is allowed except as permitted by NanoString. The award winner is responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, the grant program may not run as planned for any causes beyond the reasonable control of NanoString, then NanoString reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. These terms and conditions and any action related to this grant program will be governed by the laws of the State of Washington without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in Seattle, Washington, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.